09:48 AM EST - ESSA Pharma Inc. : has received notification from the Food and Drug Administration in the US that the Company's IND application, filed March 31, has been placed on clinical hold pending receipt by the FDA of additional chemistry and pharmaceutical data related to the stability of the drug substance and drug product and a Certificate of Analysis on drug product. ESSA Pharma Inc.
shares V.EPI are trading down $0.10 at $9.00.
